LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the effect of continuous intravenous Landiolol
injection (from 0.5 to 10 µg/kg/min during 12 hours ) up to a 15% decrease in Heart Rate (HR)
on microcirculatory vascular reactivity vs. usual tachycardia management and evaluate the
hemodynamic effects of Landiolol vs. usual management in patients with septic shock.